Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Biotech firm Targacept ends work on TC-6499 drug development after clinical trial failure
Friday, April 17, 2015WinstonSalem biotech firm Targacept announced Thursday that it has ended work on another of its drugs in development after failures during clinical trials The announcement by TargaceptNASDAQ TRGT concerned TC which researchers had hoped would be a t...
Biotech company Phosphagenics initiates Oxycodone patch dosing in phase 2 clinical trial
Friday, April 17, 2015Australian drug delivery company Phosphagenics Limited ASXPOH OTCQXPPGNY has commenced dosing in its Phase TPMOxycodone patch trial POH Study POH is a doubleblind randomised crossover Phase clinical trial investigating the safety and efficacy of...
Kangmei Pharma signs framework agreement on medicine trading ctr with Yulin govt
Friday, April 17, 2015Says signs framework agreement on Chinese medicine trading centre with Yulin government total investment at least million yuan million Says signs strategic framework agreement on health service industry with Yulin government total investment at le...
Denmark's Novo Nordisk builds $100 million insulin plant in Russia
Thursday, April 16, 2015A lot has changed in the Russian economy in the two years since Denmarks Novo Nordisk NVO started work on its million insulin plant there But with the plants opening Friday Novo emphasized that it is taking the long view on a market that is much les...
Bayer expands clinical development program for its oncology candidate, copanlisib (BAY 80-6946)
Thursday, April 16, 2015Bayer HealthCare has expanded its global clinical development program for the investigational oncology compound copanlisib BAY for the treatment of nonHodgkins lymphoma NHL Copanlisib is an intravenous panclass I phosphatidylinositolkinase PIK inhi...
U.S. FDA approves biopharmaceutical company Amgen's cardiovascular drug Corlanor
Thursday, April 16, 2015US health regulators on Wednesday approved Amgen Incs Corlanor to treat patients with chronic heart failure giving the worlds largest biotechnology company its first cardiovascular product The Food and Drug Administration approved the use of Corlano...
Medical device maker AngioDynamics invests in cancer drug delivery aspirant EmboMedics
Wednesday, April 15, 2015Devicemaker AngioDynamics threw its hat into the cancer drug delivery ring through its partnership with EmboMedics the developer of investigational chemotherapydelivering microspheres that also perform embolization The deal calls for AngioDynamics t...
Aurobindo Pharma gets USFDA nod to sell antibiotic oral suspension
Wednesday, April 15, 2015Aurobindo Pharma today said it has got final approval from the US Food and Drug Administration USFDA to make and sell its generic version of oral suspension of antibiotic Cefixime The approval by the USFDA is for strengths of mg ml and mg ml and t...
Bayer HealthCare to invest $100 million to build drugs testing facility in Berkeley
Wednesday, April 15, 2015The squarefoot structure on the southern edge of Bayers East Bay campus actually is part of a longrange strategy by the subgroup of Germanybased drug giant Bayer AG That plan has focused on upgrading facilities for research development manufacturing...
Sun Pharma collaborates with Technion for research on oncology drugs
Wednesday, April 15, 2015We are very excited about this new endeavor between Sun Pharma with the Technion We are confident that this collaboration will help us move rapidly forward with our research said Ciechanover and Binah Sun Pharmaceutical Industries Ltd and the Techni...
